| Tin M Do, MD | |
|
495 Stanyan St, San Francisco, CA 94117 | |
| (415) 750-5700 | |
| Not Available |
| Full Name | Tin M Do |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 495 Stanyan St, San Francisco, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154419034 | NPI | - | NPPES |
| 00A845660 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A84566 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| El Camino Hospital | Mountain view, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John's Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
Glioblastoma, the most widespread and lethal primary brain tumor in adults, is notoriously difficult to treat due to the surrounding lack of oxygen essential to the effectiveness of current treatment.
People who are obese and lead unhealthy lifestyles are more likely to suffer from a larger number of urinary problems, according to a population-based study of more than 5,000 men and women published in the May issue of the UK-based urology journal BJU International.
› Verified 4 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John's Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
Glioblastoma, the most widespread and lethal primary brain tumor in adults, is notoriously difficult to treat due to the surrounding lack of oxygen essential to the effectiveness of current treatment.
People who are obese and lead unhealthy lifestyles are more likely to suffer from a larger number of urinary problems, according to a population-based study of more than 5,000 men and women published in the May issue of the UK-based urology journal BJU International.
› Verified 4 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John's Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
Glioblastoma, the most widespread and lethal primary brain tumor in adults, is notoriously difficult to treat due to the surrounding lack of oxygen essential to the effectiveness of current treatment.
People who are obese and lead unhealthy lifestyles are more likely to suffer from a larger number of urinary problems, according to a population-based study of more than 5,000 men and women published in the May issue of the UK-based urology journal BJU International.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tin M Do, MD 2100 Powell St, Suite 920, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Tin M Do, MD 495 Stanyan St, San Francisco, CA 94117 Ph: (415) 750-5700 |
News Archive
A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John's Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
Glioblastoma, the most widespread and lethal primary brain tumor in adults, is notoriously difficult to treat due to the surrounding lack of oxygen essential to the effectiveness of current treatment.
People who are obese and lead unhealthy lifestyles are more likely to suffer from a larger number of urinary problems, according to a population-based study of more than 5,000 men and women published in the May issue of the UK-based urology journal BJU International.
› Verified 4 days ago
Paul Robinson, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1230 Arguello Blvd Apt 2, San Francisco, CA 94122 Phone: 415-948-8836 | |
Frederick D Pitts Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 229 7th St, San Francisco, CA 94103 Phone: 415-503-6042 Fax: 415-503-6099 | |
Georgina Lisseth Calderon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 10th Ave, Apt. 1, San Francisco, CA 94122 Phone: 323-514-0964 | |
Timothy Bauer Duncan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2333 Buchanan St, San Francisco, CA 94115 Phone: 209-342-2300 Fax: 209-524-4240 | |
Bichhuong M Dinh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3555 Cesar Chavez, San Francisco, CA 94110 Phone: 240-447-1281 | |
Dr. Lauren Elizabeth Chalwell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Potrero Avenue Department Of Emergency Medicine, San Francisco General Hospital,, San Francisco, CA 94110 Phone: 415-206-5753 | |
Dr. Jeremy Lacocque, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Potrero Ave, San Francisco, CA 94110 Phone: 628-206-8000 |